Glacier Peak Capital’s GSK GSK Stock Holding History

Glacier Peak Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,000	Closed	-$481K	–	58
2016 Q4	$481K	Buy	+10,000	New	+$494K	0.28%	71
2016 Q1	–	Sell	-21,600	Closed	-$1.09M	–	55
2015 Q4	$1.09M	Hold	21,600	–	–	0.69%	41
2015 Q3	$1.04M	Hold	21,600	–	–	0.58%	42
2015 Q2	$1.13M	Hold	21,600	–	–	0.57%	47
2015 Q1	$1.25M	Buy	+21,600	New	+$1.24M	0.61%	44
2014 Q4	–	Sell	-45,376	Closed	-$2.61M	–	66
2014 Q3	$2.61M	Buy	45,376 +33,376	+278%	+$2.05M	1.44%	25
2014 Q2	$802K	Buy	+12,000	New	+$812K	0.5%	42

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Glacier Peak Capital's GSK Position: Q1 2017 in Review

Glacier Peak Capital sold out of GSK (GSK) in Q1 2017, closing a stake of 10,000 shares — an estimated $481K sold.

Glacier Peak Capital first reported a position in GSK in Q2 2014 and held it in 7 quarters. The position peaked at $2.61M in Q3 2014. 786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

Glacier Peak Capital reported no remaining GSK position as of Q1 2017 after selling out during the quarter.
Glacier Peak Capital sold 10,000 GSK shares in Q1 2017, an estimated $481K.
Glacier Peak Capital first reported a position in GSK in Q2 2014 and held it in 7 quarters.
Glacier Peak Capital's GSK position peaked at $2.61M in Q3 2014.
786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Glacier Peak Capital's 13F filing for Q1 2017, filed 12 May 2017.